Not exact matches
Although researchers do not yet
know the biological significance of these discoveries, they say that fully cataloguing the genome may help them understand how genetic variations affect the risk of contracting diseases such as
cancer as well as how
humans grow from a single -
celled embryo into an adult.
However, some
human tumor
cells may also be hard to infect with viral therapies, Dr. Cripe reasoned, and
knowing how
cells respond in those situations could also be important to improving
cancer treatments.
«There are still many questions left to answer but we now
know that oxygen poor environments, like those often found in advanced
human breast
cancers serve as nurseries for the birth of
cancer stem cells,» says Gregg Semenza, M.D., Ph.D., the C. Michael Armstrong Professor of Medicine and a member of the Johns Hopkins Kimmel Cancer C
cancer stem
cells,» says Gregg Semenza, M.D., Ph.D., the C. Michael Armstrong Professor of Medicine and a member of the Johns Hopkins Kimmel
Cancer C
Cancer Center.
The study, «VlincRNAs controlled by retroviral elements are a hallmark of pluripotency and
cancer» found that novel non-coding parts of the
human genome
known as vlincRNAs (very long intergenic, non-coding RNAs) triggered by ancient viruses, participate in the biology of stem
cells, and in the development of
cancer.
«We now
know much more about metabolic reprogramming of cancerous tissues in
human patients, particularly that the activation of pyruvate carboxylase is important to lung
cancer cell growth and survival,» said Fan, UK professor of toxicology and faculty member of the Markey Cancer Center and CESB at the University of Ken
cancer cell growth and survival,» said Fan, UK professor of toxicology and faculty member of the Markey
Cancer Center and CESB at the University of Ken
Cancer Center and CESB at the University of Kentucky.
«In people chronically infected with hepatitis B or C,
human papillomaviruses or other viruses
known to cause
cancer, radioimmunotherapy could potentially eliminate virus - infected
cells before they're able to transform into
cancer cells.»
In preclinical experiments using
human prostate
cancer cell lines, Fu's team showed that increased PLK1 expression activated an oncogene
known as c - RAF, which has previously been shown to play a role in regulating
cell growth and division.
We don't
know if
human cancer cells that lack Hsp90 also change their chromosomes.
Over the past two years, investigators from the Perelman School of Medicine at the University of Pennsylvania have reported results from a
human trial in GBM using chimeric antigen receptor (CAR) T
cell therapy, through which patients» own T
cells were engineered to track down and kill
cancer cells that express a tumor - specific protein
known as EGFRvIII.
1965 — The Epstein - Barr virus, which causes mononucleosis, is found in the cancerous lymph node
cells of children with Burkitt's lymphoma, making it the first
known human cancer virus.
The study, conducted in both
human and mouse
cells, shows that
cancer genomes lose copies of repetitive sequences
known as ribosomal DNA.
One week after a breakthrough finding, scientists report they can reprogram
human skin
cells to behave like embryonic stem
cells without a growth factor
known to cause
cancer
Inclusion Criteria: • Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 • Have histologically or cytologically confirmed advanced or metastatic non-small
cell lung
cancer (NSCLC)(Stage IIIb or greater) • Measurable disease, as defined by Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 •
Known PD - L1 tumor status as determined by an immunohistochemistry (IHC) assay performed by the central laboratory on tissue obtained at Screening • A woman of childbearing potential must have a negative highly sensitive serum (beta -
human chorionic gonadotropin [beta - hCG]-RRB- at Screening within 14 days prior to study drug administration Inclusion Criteria for Crossover: • Participants must have been randomized to Arm A of the study and had radiographic disease progression according to RECIST 1.1 • Participants must have a mandatory biopsy at the time of disease progression according to RECIST 1.1 prior to crossing over.
Around 60 % of
human colorectal
cancers have mutations in the KRAS, BRAF or ERBB genes — all of which encode proteins coupled to the Ras pathway, a well -
known way of transmitting signals within
cells.
They fused mouse B
cells — antibody - producing
cells of the immune system — with
human myeloma (also
known as B
cell cancer)
cell lines in a new technique called hybridoma technology.
«We
knew that TET proteins were involved in
human cancer but we didn't
know how they regulated T
cell development,» says Angeliki Tsagaratou, Ph.D., an instructor in the Rao lab and the study's first author.
And we can also use what we
know about the genetics of the
human cancer to make mutations in normal
cells, and see how different mutations drive invasion.»
• Patients must have adequate coagulation (international normalized ratio (INR) or prothrombin time (PT), partial thromboplastin time (PTT) ≤ 1.5 times ULN) • Adequate liver function (total bilirubin ≤ 1.5 times the ULN, alanine aminotransferase (ALT) and aspartate aminotransferase (AST) ≤ 2.5 times ULN Exclusion Criteria: • Presence of active / uncontrolled central nervous system involvement • History of clinically significant cardiac disease; uncontrolled hypertension • Left ventricular ejection fraction (LVEF) < 45 % • Allogeneic stem
cell transplant within 100 days before first dose of study drug •
Known history of
human immunodeficiency virus (HIV) infection • Chronic or active hepatitis B or C, requiring antiviral therapy • Evidence of history of bleeding disorder, dialysis, or coexisting
cancer that is distinct in primary site or histology from the
cancer evaluated in this study • Serious, uncontrolled infection • Unresolved chronic toxicity > grade 1 from prior therapy • Use of strong CYP3A4 inhibitors or strong inducers within 7 days prior to the start of study treatment and for the duration of the study
In studies using
human cancer cell lines, a new, never - described compound
known as BMH - 21 destroyed this critical communication pathway.
The gold - platinum nanoparticles, which are about hundred thousand times thinner than a
human hair, also are efficient at converting laser radiation into heat and killing the
cancer cell, making them promising for another
cancer treatment
known as photo - thermal therapy.
Many women are «triple negative» No one yet
knows precisely why, but African - American women are roughly twice as likely as white women to have triple - negative breast
cancer — so called because tumor
cells in this particularly aggressive form of the disease test negative for estrogen receptor (ER), progesterone receptor (PR), and
human epidermal growth factor receptor 2 (HER - 2).
We
know that the bodies of both
humans and rats have natural self - repair mechanisms that not only fight
cancer cells, but other disease.
Scientists at South Dakota State University tested the effects of this substance,
known as PEITC, on
human cancer stem
cells in a Petri dish.
Anti-oxidants and phyto - nutrients are
known to have protective effects on
human cells, retard or reverse growth of
cancer cells, and prolong healthy life.
Just like the ever - growing list of disorders, it is
known to treat in
humans, acupuncture also plays a big role in combating some of the side effects that sprout as a result of
cancer cells in a dog's body.